MedPath

An innovative care model using continuous glucose monitoring metric data to provide real-time personalised care for children with diabetes.

Not Applicable
Active, not recruiting
Conditions
Diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12623000955617
Lead Sponsor
Child and Adolescent Health Service
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
113
Inclusion Criteria

Children aged 5-14 years and their parents or primary caregivers
CGM use greater than or equal to 75% of the time in the 2-week period leading up to study start
Insulin administration via multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII)

Exclusion Criteria

Children not using CGM

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Continuous glucose monitoring percentage time in range 3.9-10.0mmol/L[ Baseline, 3 months and 6 months post intervention commencement]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath